188 related articles for article (PubMed ID: 35216452)
1. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
[TBL] [Abstract][Full Text] [Related]
2. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
3. FANCA and FANCG are the major Fanconi anemia genes in the Korean population.
Park J; Chung NG; Chae H; Kim M; Lee S; Kim Y; Lee JW; Cho B; Jeong DC; Park IY
Clin Genet; 2013 Sep; 84(3):271-5. PubMed ID: 23067021
[TBL] [Abstract][Full Text] [Related]
4. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
[TBL] [Abstract][Full Text] [Related]
5. In silico study of missense variants of FANCA, FANCC and FANCG genes reveals high risk deleterious alleles predisposing to Fanconi anemia pathogenesis.
Shahid M; Azfaralariff A; Zubair M; Abdulkareem Najm A; Khalili N; Law D; Firasat S; Fazry S
Gene; 2022 Feb; 812():146104. PubMed ID: 34864095
[TBL] [Abstract][Full Text] [Related]
6. Founder haplotype analysis of Fanconi anemia in the Korean population finds common ancestral haplotypes for a FANCG variant.
Park J; Kim M; Jang W; Chae H; Kim Y; Chung NG; Lee JW; Cho B; Jeong DC; Park IY; Park MS
Ann Hum Genet; 2015 May; 79(3):153-61. PubMed ID: 25703136
[TBL] [Abstract][Full Text] [Related]
7. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
8. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
10. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
11. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
Garcia-Higuera I; Kuang Y; Denham J; D'Andrea AD
Blood; 2000 Nov; 96(9):3224-30. PubMed ID: 11050007
[TBL] [Abstract][Full Text] [Related]
12. Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia.
Doubaj Y; Zrhidri A; Elalaoui SC; Lyahyai J; El Kadiri Y; Elkassimi N; Sbiti A; El Kababri M; Hessissen L; Sefiani A
Pan Afr Med J; 2021; 39():72. PubMed ID: 34422195
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anaemia in black South African patients heterozygous for the FANCG c.637-643delTACCGCC founder mutation.
Wainstein T; Kerr R; Mitchell CL; Madaree S; Essop FB; Vorster E; Wainwright R; Poole J; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):970-3. PubMed ID: 24300640
[TBL] [Abstract][Full Text] [Related]
14. Novel Founder Mutation in
Dimishkovska M; Kotori VM; Gucev Z; Kocheva S; Polenakovic M; Plaseska-Karanfilska D
Balkan Med J; 2018 Jan; 35(1):108-111. PubMed ID: 29400309
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two novel FANCG mutations in Indian Fanconi anemia patients.
Solanki A; Kumar Selvaa C; Sheth F; Radhakrishnan N; Kalra M; Vundinti BR
Leuk Res; 2017 Feb; 53():50-56. PubMed ID: 28024295
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
18. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.
Kruyt FA; Abou-Zahr F; Mok H; Youssoufian H
J Biol Chem; 1999 Nov; 274(48):34212-8. PubMed ID: 10567393
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
Gordon SM; Buchwald M
Blood; 2003 Jul; 102(1):136-41. PubMed ID: 12649160
[TBL] [Abstract][Full Text] [Related]
20. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]